Sangamo BioSciences | SGMO - Ebit





Ebit تغيير تاريخ
Alaunos Therapeutics USD -952K 60K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 4.68B 65M 2026-09
Bayer EUR 129M 626M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Cipla INR 10.43B 1.55B 2026-09
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 2.64B 116M 2025-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Omeros USD -48.15M 7.25M 2023-09
Pfizer USD 4.85B 5.03B 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09